Iris S.
- Country
- Germany
- Department
- Brustzentrum Rhein-Ruhr Servicegesellschaft mbH
Research Overview
- Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab versus Chemotherapy in Clinical Stage II-III Triple-Negative Early Breast Cancer
- CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCER PATIENTS
- Efficacy and Safety of Giredestrant vs. Fulvestrant with CDK4/6 Inhibitor in ER+ HER2- Advanced Breast Cancer Resistant to Endocrine Therapy
Data & Insights
Has run more than one trial at 93 of 320 partner sites.
Specializations
Advanced Breast Cancer Research
The investigator specializes in treating hormone receptor-positive (HR+) and HER2-negative breast cancer, with particular emphasis on developing treatment strategies for patients who have developed resistance to conventional endocrine therapies.
- Endocrine Therapy Resistance
- ESR1 Mutation Analysis
- CDK4/6 Inhibitor Combinations
Their work includes evaluation of novel therapeutic agents in combination with established treatments for advanced disease states.
Early-Stage Breast Cancer
The investigator conducts research in HER2-positive early breast cancer treatment, focusing on innovative therapeutic approaches for locally advanced and inflammatory disease presentations.
- Neoadjuvant Therapy
- Pathological Complete Response Assessment
- Novel Antibody-Drug Conjugates
Their research encompasses evaluation of treatment sequences and combinations for optimal patient outcomes in early-stage disease.
Therapeutic Innovation
The investigator explores comprehensive molecular and temporal patterns in breast cancer treatment response, with particular attention to novel therapeutic agents and their efficacy profiles.
- Treatment Response Analysis
- Survival Outcomes Assessment
- First-line Therapeutic Strategies
Their research includes systematic evaluation of progression-free and overall survival metrics in advanced breast cancer settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.